[1]
Toscano, S.; Patti, F. CSF biomarkers in multiple sclerosis: Beyond neuroinflammation. Neuroimmunol. Neuroinflamm., 2021, 8, 14-41.
[http://dx.doi.org/10.20517/2347-8659.2020.12]
[http://dx.doi.org/10.20517/2347-8659.2020.12]
[2]
Califf, R.M. Biomarker definitions and their applications. Exp. Biol. Med. (Maywood), 2018, 243(3), 213-221.
[http://dx.doi.org/10.1177/1535370217750088]
[http://dx.doi.org/10.1177/1535370217750088]
[3]
Mobed, A.; Razavi, S.; Ahmadalipour, A.; Shakouri, S.K.; Koohkan, G. Biosensors in Parkinson’s disease. Clin. Chim. Acta, 2021, 518, 51-58.
[http://dx.doi.org/10.1016/j.cca.2021.03.009]
[http://dx.doi.org/10.1016/j.cca.2021.03.009]
[4]
Zhou, L.; Wang, M-H.; Wang, J-P.; Ye, Z-Z. Application of biosensor surface immobilization methods for aptamer. Chin. J. Anal. Chem., 2011, 39(3), 432-438.
[5]
Mikuła, E.; Katrlík, J.; Rodrigues, L.R. Electrochemical aptasensors for Parkinson’s disease biomarkers detection. Curr. Med. Chem., 2022, 29(37), 5795-5814.
[http://dx.doi.org/10.2174/0929867329666220520123337]
[http://dx.doi.org/10.2174/0929867329666220520123337]
[6]
Sen, R.K.; Prabhakar, P.; Bisht, N.; Patel, M.; Mishra, S.; Yadav, A.K.; Venu, D.V.; Gupta, G.K.; Solanki, P.R.; Ramakrishnan, S.; Mondal, D.; Srivastava, A.K.; Dwivedi, N.; Dhand, C. 2D materials-based aptamer biosensors: Present status and way. Curr. Med. Chem., 2022, 29(37), 5815-5849.
[http://dx.doi.org/10.2174/0929867328666211213115723]
[http://dx.doi.org/10.2174/0929867328666211213115723]
[7]
Sousa, D.A.; Carneiro, M.; Ferreira, D.; Moreira, F.T.C.; Sales, M.G.F.; Rodrigues, L.R. Recent advances in the selection of cancer-specific aptamers for the development of biosensors. Curr. Med. Chem., 2022, 29(37), 5850-5880.
[http://dx.doi.org/10.2174/0929867329666220224155037]
[http://dx.doi.org/10.2174/0929867329666220224155037]
[8]
Hassani, S.; Maghsoudi, A.S.; Akmal, M.R.; Shoeibi, S.; Ghadipasha, F.; Mousavi, T.; Ganjali, M.R.; Hosseini, R.; Abdollahi, M. A novel approach for designing electrochemical aptamer-based biosensor for ultrasensitive detection of zearalenone as a prevalent estrogenic mycotoxin. Curr. Med. Chem., 2022, 29(37), 5881-5894.
[http://dx.doi.org/10.2174/0929867328666211214165814]
[http://dx.doi.org/10.2174/0929867328666211214165814]
[9]
Crulhas, B.P.; Basso, C.R.; Castro, G.R.; Pedrosa, V.A. Detection of prostate cancer biomarker PCA3 by using aptasensors. Curr. Med. Chem., 2022, 29(37), 5895-5902.
[http://dx.doi.org/10.2174/0929867329666220607162250]
[http://dx.doi.org/10.2174/0929867329666220607162250]
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Article Metrics
8